PRICE T ROWE ASSOCIATES INC /MD/ - F-STAR THERAPEUTICS INC ownership

F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F-STAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 14.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of F-STAR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$398
-99.9%
63,0470.0%0.00%
Q3 2022$323,000
-91.5%
63,047
-89.7%
0.00%
Q2 2022$3,816,000
+36.1%
609,654
-22.8%
0.00%
Q1 2022$2,803,000
-34.9%
789,590
-8.0%
0.00%
Q4 2021$4,308,000
-28.5%
858,095
+4.2%
0.00%
-100.0%
Q3 2021$6,027,000
-15.2%
823,382
-0.5%
0.00%0.0%
Q2 2021$7,110,000827,7280.00%
Other shareholders
F-STAR THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 714,285$6,136,0001.28%
Boxer Capital, LLC 1,751,428$15,045,0000.53%
Atlas Venture Advisors, Inc. 574,996$4,939,0000.51%
Monashee Investment Management LLC 400,000$3,436,0000.41%
Connolly Sarah T. 53,001$455,0000.37%
Rock Springs Capital Management LP 1,054,232$9,056,0000.18%
Eversept Partners, LP 100,000$859,0000.06%
Maven Securities LTD 144,932$1,257,0000.05%
Point72 Asset Management, L.P. 1,075,000$9,234,0000.04%
Private Capital Advisors, Inc. 13,083$112,0000.02%
View complete list of F-STAR THERAPEUTICS INC shareholders